TD Asset Management’s Rapid Micro Biosystems RPID Stock Holding History

TD Asset Management’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-58,496	Closed	-$76.6K	–	1461
2023 Q1	$76.6K	Sell	58,496 -58,688	-50%	-$76.2K	﹤0.01%	1404
2022 Q4	$132K	Sell	117,184 -16,630	-12%	-$40.3K	﹤0.01%	1407
2022 Q3	$467K	Hold	133,814	–	–	﹤0.01%	1305
2022 Q2	$575K	Hold	133,814	–	–	﹤0.01%	1268
2022 Q1	$909K	Buy	133,814 +50,740	+61%	+$374K	﹤0.01%	1248
2021 Q4	$884K	Buy	83,074 +34,758	+72%	+$543K	﹤0.01%	1297
2021 Q3	$892K	Buy	+48,316	New	+$998K	﹤0.01%	1279

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

TD Asset Management's RPID Position: Q2 2023 in Review

TD Asset Management sold out of Rapid Micro Biosystems (RPID) in Q2 2023, closing a stake of 58,496 shares — an estimated $76.6K sold.

TD Asset Management first reported a position in RPID in Q3 2021 and held it in 7 quarters. The position peaked at $909K in Q1 2022. 24 funds tracked by Wall St. Rank hold RPID as of Q2 2023.

TD Asset Management reported no remaining Rapid Micro Biosystems position as of Q2 2023 after selling out during the quarter.
TD Asset Management sold 58,496 Rapid Micro Biosystems shares in Q2 2023, an estimated $76.6K.
TD Asset Management first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 7 quarters.
TD Asset Management's Rapid Micro Biosystems position peaked at $909K in Q1 2022.
24 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2023.

Based on TD Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.